Literature DB >> 20007854

Resting and exercise-induced IL-6 levels in children with Type 1 diabetes reflect hyperglycemic profiles during the previous 3 days.

Jaime S Rosa1, Rebecca L Flores, Stacy R Oliver, Andria M Pontello, Frank P Zaldivar, Pietro R Galassetti.   

Abstract

Poor glycemic control in Type 1 diabetes (T1DM) causes long-term cardiovascular complications, at least in part via chronic, low-grade inflammation associated with recurrent hyperglycemia. While physical activity can reduce both inflammation and cardiovascular risks, the underlying molecular mechanisms remain unclear. This is particularly important for T1DM children, for whom the prevention of long-term cardiovascular complications must include optimization of exercise-related anti-inflammatory strategies. We therefore studied the effect of prior hyperglycemia on resting and exercise-induced inflammatory status (plasma IL-6) in T1DM children. Glycemia was continuously recorded with a continuous glucose monitoring system (CGMS) system for 63 h preceding a 30-min intermittent cycling exercise protocol at approximately 80% peak rate of oxygen uptake (VO2max). Euglycemia (4.4-6.1 mM) was maintained for 90 min before, during, and 30 min after exercise. IL-6 plasma concentration (pg/ml) was measured at baseline, at end exercise, and 30 min postexercise. Subjects were then divided into quartiles based on average glycemia during the CGMS recording. IL-6 levels (pg/ml) were lowest in the quartile with lowest average 3-day glycemia and increased proportionally to greater hyperglycemic exposure; this was observed at baseline (0.86 +/- 0.10, 1.06 +/- 0.16, 1.14 +/- 0.14, 1.20 +/- 0.16), absolute IL-6 change (Delta) at end exercise (0.20 +/- 0.16, 0.32 +/- 0.10, 0.48 +/- 0.09, 0.62 +/- 0.13), and Delta at 30 min postexercise (0.49 +/- 0.13, 0.71 +/- 0.16, 0.89 +/- 0.14, 1.38 +/- 0.33). Therefore, poorly controlled glycemic profile, even in the 63 h preceding an exercise challenge, can alter inflammatory adaptation in T1DM children. Our data underscore the necessity to fully understand all molecular aspects of physical activity to provide the scientific rationale for exercise regimens that will be able to maximize health benefits for T1DM children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007854      PMCID: PMC2822671          DOI: 10.1152/japplphysiol.01083.2009

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  50 in total

Review 1.  Anti-inflammatory cytokines.

Authors:  S M Opal; V A DePalo
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

2.  Increased inflammatory response of blood cells to repeated bout of endurance exercise.

Authors:  Jorid Degerstrøm; Bjarne Østerud
Journal:  Med Sci Sports Exerc       Date:  2006-07       Impact factor: 5.411

3.  Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy.

Authors:  E Lindmark; E Diderholm; L Wallentin; A Siegbahn
Journal:  JAMA       Date:  2001-11-07       Impact factor: 56.272

4.  Effect of prior hyperglycemia on IL-6 responses to exercise in children with type 1 diabetes.

Authors:  P R Galassetti; K Iwanaga; A M Pontello; F P Zaldivar; R L Flores; J K Larson
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-12-06       Impact factor: 4.310

5.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

6.  Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes.

Authors:  Judith M Willemsen; Jan W Westerink; Geesje M Dallinga-Thie; Anton-Jan van Zonneveld; Carlo A Gaillard; Ton J Rabelink; Eelco J P de Koning
Journal:  J Cardiovasc Pharmacol       Date:  2007-01       Impact factor: 3.105

Review 7.  Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy.

Authors:  Sho-ichi Yamagishi; Tsutomu Imaizumi
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

Review 8.  Type 1 diabetes: pathogenesis and prevention.

Authors:  Kathleen M Gillespie
Journal:  CMAJ       Date:  2006-07-18       Impact factor: 8.262

9.  Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises.

Authors:  Frankie B Stentz; Guillermo E Umpierrez; Ruben Cuervo; Abbas E Kitabchi
Journal:  Diabetes       Date:  2004-08       Impact factor: 9.461

10.  A self-report measure of pubertal status: Reliability, validity, and initial norms.

Authors:  A C Petersen; L Crockett; M Richards; A Boxer
Journal:  J Youth Adolesc       Date:  1988-04
View more
  8 in total

1.  Altered inflammatory, oxidative, and metabolic responses to exercise in pediatric obesity and type 1 diabetes.

Authors:  Jaime S Rosa; Stacy R Oliver; Rebecca L Flores; Jerry Ngo; Ginger L Milne; Frank P Zaldivar; Pietro R Galassetti
Journal:  Pediatr Diabetes       Date:  2011-03-28       Impact factor: 4.866

Review 2.  Differential control of muscle mass in type 1 and type 2 diabetes mellitus.

Authors:  David Sala; Antonio Zorzano
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

3.  Fasting glucose level modulates cell surface expression of CD11b and CD66b in granulocytes and monocytes of patients with type 2 diabetes.

Authors:  Peter Horvath; Stacy R Oliver; Goutham Ganesan; Frank P Zaldivar; Shlomit Radom-Aizik; Pietro R Galassetti
Journal:  J Investig Med       Date:  2013-08       Impact factor: 2.895

4.  Effects of the dietary approaches to stop hypertension (DASH) diet on glucose variability in youth with Type 1 diabetes.

Authors:  Abigail D Peairs; Amy S Shah; Suzanne Summer; Melody Hess; Sarah C Couch
Journal:  Diabetes Manag (Lond)       Date:  2017

5.  Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome.

Authors:  Lori D Wilson; Sadeeka Al-Majid; Cyril S Rakovski; Christina D Schwindt
Journal:  J Inflamm (Lond)       Date:  2012-06-21       Impact factor: 4.981

6.  Inflammatory cytokine profiles during exercise in obese, diabetic, and healthy children.

Authors:  Jaime S Rosa; Shirin Heydari; Stacy R Oliver; Rebecca L Flores; Andria M Pontello; Milagros Ibardolaza; Pietro R Galassetti
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011

7.  Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.

Authors:  Matthew D Campbell; Mark Walker; Michael I Trenell; Steven Luzio; Gareth Dunseath; Daniel Tuner; Richard M Bracken; Stephen C Bain; Mark Russell; Emma J Stevenson; Daniel J West
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

8.  Aerobic and combined exercise sessions reduce glucose variability in type 2 diabetes: crossover randomized trial.

Authors:  Franciele R Figueira; Daniel Umpierre; Karina R Casali; Pedro S Tetelbom; Nicoli T Henn; Jorge P Ribeiro; Beatriz D Schaan
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.